Pharmaceutical Industry Information Portal

HomeNews

News

Pharmasyntez to continue producing anti-COVID-19 drug remdesivir without patent for a year

The Russian government on December 30, 2021 approved the extension for one year of a decree originally issued last year to grant Russian drugmaker...

Japan Is Developing A COVID-19 Vaccine That Will Provide Lifelong Immunity

Researchers at the Tokyo Metropolitan Institute of Medical Science are working on a COVID-19 vaccine that not only delivers lifelong immunity against the SARS-CoV-2...

ROSATOM Successfully Tests Radiopharmaceuticals Production Equipment in Bolivia

The highest Center of Nuclear Technology Research and Development in the world by altitude, currently under construction by the Rosatom State Corporation in El...

Russia develops testing system capable of detecting Omicron coronavirus variant

A testing system capable of simultaneously detecting the coronavirus genome and deciding if it is the Omicron variant of the virus has been developed...

Blood plasma-based drug against COVID-19 successfully passes clinical trials

The COVID-globulin medicine against coronavirus based on convalescent blood plasma has successfully passed clinical trials and received a permanent certification by the Russian Health...

Russian Ministry of Health included injectable Areplivir® in the guidelines for the treatment of COVID-19

The Ministry of Health of the Russian Federation has included the injectable form of the direct-acting antiviral drug Areplivir® (favipiravir) in the updated, fourteenth, version...
spot_img

Expert Articles

spot_img